Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Cash from Financing Activities (2023 - 2026)

BrightSpring Health Services filings provide 4 years of Cash from Financing Activities readings, the most recent being -$70.0 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 18.6% to -$70.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$141.9 million, a 86.33% decrease, with the full-year FY2025 number at -$157.9 million, down 195.88% from a year prior.
  • Cash from Financing Activities hit -$70.0 million in Q1 2026 for BrightSpring Health Services, down from -$50.5 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $154.8 million in Q1 2024 to a low of -$143.9 million in Q4 2023.
  • Median Cash from Financing Activities over the past 4 years was -$13.1 million (2025), compared with a mean of -$10.8 million.
  • Biggest five-year swings in Cash from Financing Activities: surged 722.01% in 2024 and later crashed 167.12% in 2025.
  • BrightSpring Health Services' Cash from Financing Activities stood at -$143.9 million in 2023, then skyrocketed by 65.58% to -$49.6 million in 2024, then fell by 1.91% to -$50.5 million in 2025, then crashed by 38.65% to -$70.0 million in 2026.
  • The last three reported values for Cash from Financing Activities were -$70.0 million (Q1 2026), -$50.5 million (Q4 2025), and -$13.1 million (Q3 2025) per Business Quant data.